Arcturus Therapeutics Holdings Non-Current Deferred Revenue (Quarterly) Insights

Arcturus Therapeutics Holdings, Inc. (ARCT)

7.53 +0.75 (+11.06%) USD | NASDAQ | Jan 12, 16:00

7.68 +0.15 (+1.99%) After-Hours: 20:00

View Non-Current Deferred Revenue (Quarterly) for ARCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Inovio Pharmaceuticals, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Novavax, Inc.	Upgrade
Sangamo Therapeutics, Inc.	Upgrade
Myomo, Inc.	--